Haidong Dong
0000-0002-5782-2983
Publication & Citation Trends
Most Cited Works
Publications
431 total
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response PDF
Cited by 2,729
OpenAlex
PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression PDF
Cited by 529
OpenAlex
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Cited by 426
OpenAlex
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL PDF
Cited by 411
OpenAlex
PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
Cited by 565
OpenAlex
PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata PDF
Cited by 438
OpenAlex
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up PDF
Cited by 868
OpenAlex
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity PDF
Cited by 998
OpenAlex
Research Topics
Cancer Immunotherapy and Biomarkers
(230)
Immunotherapy and Immune Responses
(157)
CAR-T cell therapy research
(116)
Immune Cell Function and Interaction
(86)
Immune cells in cancer
(32)
Frequent Co-Authors
Affiliations
Kunming University of Science and Technology
Human Genome Sciences (United States)
Cleveland Clinic
Mayo Clinic
Johns Hopkins University